TRACON PHARMACEUTICALS

tracon-pharmaceuticals-logo

TRACON develops targeted therapies for cancer utilizing a capital efficient, CRO independent, product development platform. The Companyโ€™s clinical-stage pipeline includes: Envafolimab, a PD-L1 single-domain antibody given by rapid subcutaneous injection that is being studied in the pivotal ENVASARC trial for sarcoma; TRC102, a Phase 2 small molecule drug candidate for the treatment of lung cancer; and TJ004309, a CD73 antibody in Phase 1 development for the treatment of advanced solid tumors. ... TRACON is actively seeking additional corporate partnerships whereby it leads U.S. regulatory and clinical development, shares in the cost and risk of clinical development, and leads U.S. commercialization. In these partnerships TRACON believes it can serve as a solution for companies without clinical and commercial capabilities in the United States.

#SimilarOrganizations #People #Financial #Event #Website #More

TRACON PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Medical Device

Founded:
2006-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.traconpharma.com

Total Employee:
11+

Status:
Active

Contact:
(858) 550-0780

Email Addresses:
[email protected]

Total Funding:
73.04 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx


Similar Organizations

adamis-pharmaceuticals-logo

Adamis Pharmaceuticals

Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.

asklepios-biopharmaceutical-logo

Asklepios BioPharmaceutical

Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.

anchiano-therapeutics-logo

Anchiano Therapeutics

Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

sesen-bio-inc-logo

Sesen Bio, Inc.

Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

mast-therapeutics-logo

Mast Therapeutics

Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.

novabay-pharmaceuticals-logo

NovaBay Pharmaceuticals

NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.

iveric-bio-logo

IVERIC bio

IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.


Current Advisors List

not_available_image

Kenji Harada Board of Director @ TRACON Pharmaceuticals
Board_member

Current Employees Featured

not_available_image

Scott Brown
Scott Brown Chief Accounting Officer and Head of Finance @ TRACON Pharmaceuticals
Chief Accounting Officer and Head of Finance

not_available_image

Bonne Adams
Bonne Adams EVP Clinical Operations @ TRACON Pharmaceuticals
EVP Clinical Operations
2019-01-01

not_available_image

Patricia Bitar
Patricia Bitar CFO @ TRACON Pharmaceuticals
CFO

charles-p-theuer_image

Charles P. Theuer
Charles P. Theuer President and CEO @ TRACON Pharmaceuticals
President and CEO
2006-07-01

not_available_image

Mark Wiggins
Mark Wiggins Chief Business Officer @ TRACON Pharmaceuticals
Chief Business Officer

Founder


charles-p-theuer_image

Charles P. Theuer

Stock Details


Company's stock symbol is NASDAQ:TCON

Investors List

johnson-johnson-innovation_image

Johnson & Johnson Innovation

Johnson & Johnson Innovation investment in Post-IPO Equity - TRACON Pharmaceuticals

brookline-venture-partners_image

Brookline Venture Partners

Brookline Venture Partners investment in Series B - TRACON Pharmaceuticals

venture-capital_image

Arcus Ventures

Arcus Ventures investment in Series B - TRACON Pharmaceuticals

sahsen-ventures_image

Sahsen Ventures

Sahsen Ventures investment in Series B - TRACON Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series B - TRACON Pharmaceuticals

nextech-invest_image

Nextech Invest

Nextech Invest investment in Series B - TRACON Pharmaceuticals

biomed-ventures_image

BioMed Ventures

BioMed Ventures investment in Series B - TRACON Pharmaceuticals

venture-capital_image

Arcus Ventures

Arcus Ventures investment in Series A - TRACON Pharmaceuticals

nextech-invest_image

Nextech Invest

Nextech Invest investment in Series A - TRACON Pharmaceuticals

jafco-co-ltd_image

JAFCO

JAFCO investment in Series A - TRACON Pharmaceuticals

Newest Events participated

oncology-strategy-meeting-us-west-coast-2018_event_image Participated in Oncology Strategy Meeting US West Coast 2018 on 2018-05-14 as speaker

Official Site Inspections

http://www.traconpharma.com Semrush global rank: 3.68 M Semrush visits lastest month: 3.79 K

  • Host name: 209.182.196.37
  • IP address: 209.182.196.37
  • Location: Los Angeles United States
  • Latitude: 33.956
  • Longitude: -118.3887
  • Metro Code: 803
  • Timezone: America/Los_Angeles
  • Postal: 90045

Loading ...

More informations about "TRACON Pharmaceuticals" on Search Engine